414 related articles for article (PubMed ID: 1769066)
21. Current challenges in non-invasive insulin delivery systems: a comparative review.
Khafagy el-S; Morishita M; Onuki Y; Takayama K
Adv Drug Deliv Rev; 2007 Dec; 59(15):1521-46. PubMed ID: 17881081
[TBL] [Abstract][Full Text] [Related]
22. Emerging strategies for the transdermal delivery of peptide and protein drugs.
Schuetz YB; Naik A; Guy RH; Kalia YN
Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary drug delivery: physiologic and mechanistic aspects.
Yu J; Chien YW
Crit Rev Ther Drug Carrier Syst; 1997; 14(4):395-453. PubMed ID: 9450176
[TBL] [Abstract][Full Text] [Related]
24. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
25. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
Liu Y; Lu WL; Zhang X; Wang XQ; Zhang H; Zhang Q
Peptides; 2005 Mar; 26(3):423-30. PubMed ID: 15652649
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
28. Buccal drug delivery.
Smart JD
Expert Opin Drug Deliv; 2005 May; 2(3):507-17. PubMed ID: 16296771
[TBL] [Abstract][Full Text] [Related]
29. Chemical permeation enhancers for transbuccal drug delivery.
Hassan N; Ahad A; Ali M; Ali J
Expert Opin Drug Deliv; 2010 Jan; 7(1):97-112. PubMed ID: 20017661
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of alternative insulin delivery systems.
Strack T
Curr Opin Investig Drugs; 2010 Apr; 11(4):394-401. PubMed ID: 20336587
[TBL] [Abstract][Full Text] [Related]
31. Water-in-oil microemulsions for effective transdermal delivery of proteins.
Russell-Jones G; Himes R
Expert Opin Drug Deliv; 2011 Apr; 8(4):537-46. PubMed ID: 21413905
[TBL] [Abstract][Full Text] [Related]
32. Palatal mucosa as a route for systemic drug delivery: A review.
Shakya P; Madhav NV; Shakya AK; Singh K
J Control Release; 2011 Apr; 151(1):2-9. PubMed ID: 21059376
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional matrices for oral peptide delivery.
Bernkop-Schnürch A; Walker G
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
[TBL] [Abstract][Full Text] [Related]
34. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
36. Factors of importance for a successful delivery system for proteins.
van de Weert M; Jorgensen L; Horn Moeller E; Frokjaer S
Expert Opin Drug Deliv; 2005 Nov; 2(6):1029-37. PubMed ID: 16296807
[TBL] [Abstract][Full Text] [Related]
37. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
Sahni JK; Chopra S; Ahmad FJ; Khar RK
J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
[TBL] [Abstract][Full Text] [Related]
38. Orotransmucosal drug delivery systems: a review.
Madhav NV; Shakya AK; Shakya P; Singh K
J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
[TBL] [Abstract][Full Text] [Related]
39. Is the oral route possible for peptide and protein drug delivery?
Morishita M; Peppas NA
Drug Discov Today; 2006 Oct; 11(19-20):905-10. PubMed ID: 16997140
[TBL] [Abstract][Full Text] [Related]
40. [Site-specific drug delivery systems. III. Nasal drug delivery].
Szente V; Zelkó R
Acta Pharm Hung; 2008; 78(2):87-90. PubMed ID: 18807389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
